Toggle navigation
Home
Search
Services
Blog
Contact
About
Develop Monoclonal Antibodies to Tumor Growth Factors
Ranken, Raymond
Biocircuits Corporation, Burlingame, CA, United States
Search 7 grants from Raymond Ranken
Search grants from Biocircuits Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Rapid screening of gene-edited cells
Restoring anti-tumor immunity in the microenvironment of head and neck cancer
Protein and Energy Needs in Children with Sickle Cell Anemia
Antiviral Activity of Human Lactoferrin
Support Services to Diabetes Coordinating Committee
Recently added grants:
Mechanisms and significance of intestinal cell proliferation in Vibrio parahaemolyticus infection
Functional immune tolerance to non-inherited maternal antigen
Novel next-generation sequencing assay for monitoring multidrug resistant tuberculosis treatment in the setting of HIV infection
Epigenetic Reprogramming of Monocyte Functions during Acute Uncomplicated Malaria in Kenyan Children
Combatting natural resistance and persistence in non-TB mycobacterial disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057762-000
Application #
3613353
Study Section
Project Start
1985-09-23
Project End
Budget Start
1985-09-23
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Biocircuits Corporation
Department
Type
DUNS #
City
Burlingame
State
CA
Country
United States
Zip Code
94010
Comments
Be the first to comment on Raymond Ranken's grant